Options Expiration

No doubt where they are trying to close it today. I still believe AMRN can get to $13 on a strongly positive ADCOM vote and $16 on approval in Dec. or before. If we get NCE also, $19 is probably doable. If those 3 things occur, a near-term (within 6 months) buyout moves to about a 75% probability.

I was on the same boat like you since last year, very optimistic about this company and its product Vascepa.
But it had lost 2/3 of its value from its peak last year. Now, I'm just waiting for some company to buy Amrin
in order for those shorties and hedgies to go away. Every time Amrin makes an upward move, it loses its
gains right away. The only solution is for some big pharma to take over.

Yahoo! Finance Worldwide

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.